| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
388 Abdominal incision site recurrence in a patient with endometrial adenocarcinoma
|
Fernandez, P.
|
|
|
30 |
S3 |
p. A161
|
artikel
|
| 2 |
162 Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates
|
Van Kol, K.
|
|
|
30 |
S3 |
p. A71
|
artikel
|
| 3 |
424 A carcinoid tumor arising from a mature cystic teratoma in a 33-year old patient: a case report
|
Billod, J.
|
|
|
30 |
S3 |
p. A176-A177
|
artikel
|
| 4 |
345 A case of mixed adenocarcinoma of uterus with bladder invasion originating from adenomyosis
|
Nakashima, A.
|
|
|
30 |
S3 |
p. A141-A142
|
artikel
|
| 5 |
56 A case on aggressive angiomyxoma of the vagina
|
Imperio-Onglao, R.
|
|
|
30 |
S3 |
p. A33
|
artikel
|
| 6 |
79 Activity of chemotherapy in recurrent uterine serous carcinoma
|
Beavers, R.
|
|
|
30 |
S3 |
p. A43
|
artikel
|
| 7 |
234 Addressing variation in preoperative workup of high-grade endometrial carcinoma
|
Jamieson, A.
|
|
|
30 |
S3 |
p. A96
|
artikel
|
| 8 |
247 Adenocarcinoma in situ of the cervix – evaluation of patients with conservative treatment in Southern Brazil
|
Hoefel, J.
|
|
|
30 |
S3 |
p. A101
|
artikel
|
| 9 |
224 Adjuvant chemotherapy in surgical stage I or II endometrioid endometrial cancer with myometrial invasion >50%: a multicenter retrospective study with long-term follow-up
|
Garzon, S.
|
|
|
30 |
S3 |
p. A92-A93
|
artikel
|
| 10 |
96 Adjuvant treatment for adenosarcoma confined to the uterus provides no survival benefit
|
Nasioudis, D.
|
|
|
30 |
S3 |
p. A47-A48
|
artikel
|
| 11 |
296 Adult granulosa cell tumor of the ovary: a study of 10 cases
|
Bacha, D.
|
|
|
30 |
S3 |
p. A122
|
artikel
|
| 12 |
199 A feasibility study of robotic radical hysterectomy in patients with T1b1–2/2a1, N0 cervical cancer
|
Todo, Y.
|
|
|
30 |
S3 |
p. A85
|
artikel
|
| 13 |
48 A local study on survival outcome and prognostic significance of lower uterine segment involvement in early stage endometrioid endometrial carcinoma
|
Abrenica, J.
|
|
|
30 |
S3 |
p. A31
|
artikel
|
| 14 |
8 A multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic hysterectomy for the treatment of low-risk endometrial cancer: the ROMANHY trial (NCT:02762214)
|
Gueli Alletti, S.
|
|
|
30 |
S3 |
p. A5-A7
|
artikel
|
| 15 |
116 Analysis of histopathological features, molecular results and serum tumour markers in cases of fallopian tube involvement by metastatic gastrointestinal adenocarcinoma
|
Basha Mohamed, M.
|
|
|
30 |
S3 |
p. A53
|
artikel
|
| 16 |
47 An audit of the completeness of the pathological request form for the diagnosis of possible ovarian malignancy in UK tertiary cancer centre
|
Daas, M.
|
|
|
30 |
S3 |
p. A30
|
artikel
|
| 17 |
110 A new insight into resolvin E3 as the itraconazole induced anticancer effect on cervical cancer
|
Ueda, T.
|
|
|
30 |
S3 |
p. A51-A52
|
artikel
|
| 18 |
180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer
|
Yue, Y.
|
|
|
30 |
S3 |
p. A78
|
artikel
|
| 19 |
152 Anxiety was expressed more in gynecologic cancer patients on treatment: a retrospective study from Japan under the statement of emergency for COVID-19 pandemic
|
Mogami, T.
|
|
|
30 |
S3 |
p. A67
|
artikel
|
| 20 |
165 Applicability of duke activity scale index (DASI) in perioperative prediction of postoperative complications for gynaeoncology patients
|
Sevinyan, L.
|
|
|
30 |
S3 |
p. A72
|
artikel
|
| 21 |
169 A prospective interventional study evaluating awareness and knowledge about genetic aspects of breast cancer and the effect of educational intervention: a real-life experience
|
Kumar, N.
|
|
|
30 |
S3 |
p. A74
|
artikel
|
| 22 |
451 A prospective study on metronomic scheduling of non-chemotherapeutic drugs in advanced epithelial ovarian cancers
|
Shivdas, S.
|
|
|
30 |
S3 |
p. A187-A188
|
artikel
|
| 23 |
297 A prospective study to identify rates of SARS-CoV-2 virus in the peritoneum and lower genital tract of patients having surgery
|
Jones, D.
|
|
|
30 |
S3 |
p. A122
|
artikel
|
| 24 |
288 A rare case of nasopharyngeal carcinoma metastasis to male breast
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A117
|
artikel
|
| 25 |
290 Are obstetrics and gynaecology trainees confident and competent in the care of frail gynaecological oncology patients?
|
Owens, G.
|
|
|
30 |
S3 |
p. A117-A118
|
artikel
|
| 26 |
363 A retrospective cohort study for feasibility of laparoscopic hysterectomy in patients with stage IA1 cervical cancer
|
Yamada, R.
|
|
|
30 |
S3 |
p. A149
|
artikel
|
| 27 |
103 Artificial intelligence publication trends in reproductive cancers – who is being left behind?
|
Chan, J.
|
|
|
30 |
S3 |
p. A49-A50
|
artikel
|
| 28 |
410 A simple surgical technique of groin dissection in genitourinary cancers: A single centre experience
|
Kumar, N.
|
|
|
30 |
S3 |
p. A170-A171
|
artikel
|
| 29 |
227 Assessment of cervical cancer screening in Kazakhstan
|
Kaidarova, D.
|
|
|
30 |
S3 |
p. A94
|
artikel
|
| 30 |
225 Association between the gynecologic imaging reporting and data system in adnexal masses and the type of specialist: gynecologist vs gynecologic oncologist
|
Esquivel, A.
|
|
|
30 |
S3 |
p. A93-A94
|
artikel
|
| 31 |
81 A study on the knowledge and awareness of cervical cancer among college students and assessing the impact of training sessions on cervical cancer awareness
|
Rajanbabu, A.
|
|
|
30 |
S3 |
p. A43
|
artikel
|
| 32 |
223 A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high grade serous ovarian cancer
|
Hawarden, A.
|
|
|
30 |
S3 |
p. A92
|
artikel
|
| 33 |
38 A training program to build capacity for cervical cancer prevention in Mozambique
|
Salcedo, M.
|
|
|
30 |
S3 |
p. A25
|
artikel
|
| 34 |
Author Index
|
|
|
|
30 |
S3 |
p. A201-A210
|
artikel
|
| 35 |
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
|
Ledermann, J.
|
|
|
30 |
S3 |
p. A1
|
artikel
|
| 36 |
126 A 10 year clinico-pathological study of residual/recurrent borderline ovarian tumours in young females undergoing fertility-preserving surgery
|
Toomey, S.
|
|
|
30 |
S3 |
p. A56-A57
|
artikel
|
| 37 |
286 Barriers and opportunities for optimizing pathology mentoring in the project ECHO tumor board program of the IGC:A pilot examination of adequacy of pathology case presentations
|
Plotkin, A.
|
|
|
30 |
S3 |
p. A116
|
artikel
|
| 38 |
354 Bevacizumab with metronomic oral cyclophosphamide for patients with recurrent cervical cancer
|
Isono, R.
|
|
|
30 |
S3 |
p. A145-A146
|
artikel
|
| 39 |
338 Body image and sexual function in postmenopausal women after surgery for breast cancer
|
Kaabia, O.
|
|
|
30 |
S3 |
p. A137-A138
|
artikel
|
| 40 |
66 Bone health in gynaecological oncology: a survey of tertiary care clinicians’ attitudes and practices in the prevention and management of cancer treatment-induced bone loss
|
O’Gorman, C.
|
|
|
30 |
S3 |
p. A37
|
artikel
|
| 41 |
217 Breast cancer in cap bon: epidemiological and histo-prognostic features
|
Triki, A.
|
|
|
30 |
S3 |
p. A90
|
artikel
|
| 42 |
177 Camrelizumab combined with apatinib for refractory gestational trophoblastic neoplasia: A phase 2, single-arm, prospective Study
|
Cheng, H.
|
|
|
30 |
S3 |
p. A76-A77
|
artikel
|
| 43 |
64 Can chemotherapy change tumor BRCA status and affect susceptibility to treatment?
|
D’Indinosante, M.
|
|
|
30 |
S3 |
p. A37
|
artikel
|
| 44 |
21 Can conisation specimens predict sentinel lymph node status in early-stage cervical cancer? A senticol group study
|
Mereaux, J.
|
|
|
30 |
S3 |
p. A15
|
artikel
|
| 45 |
72 Can intraoperative visual examination of diaphragmatic peritoneum be a reliable tool to modulate the extent of interval debulking surgery in advanced ovarian cancer?
|
Vargiu, V.
|
|
|
30 |
S3 |
p. A40-A41
|
artikel
|
| 46 |
394 CA125 normalization following neoadjuvant chemotherapy complementing the chemotherapy response system in the prognostication of patients with high-grade serous ovarian carcinoma
|
Li, J.
|
|
|
30 |
S3 |
p. A164
|
artikel
|
| 47 |
209 Case report of a COVID 19 patient presenting with acute abdomen and diagnosed to have high grade serous ovarian carcinoma
|
Basha Mohamed, M.
|
|
|
30 |
S3 |
p. A88
|
artikel
|
| 48 |
292 Case report: recurrent paravaginal aggressive angiomyxoma five years after initial excision and diagnosis
|
Smith, L.
|
|
|
30 |
S3 |
p. A118-A119
|
artikel
|
| 49 |
68 Cervical abnormalities in a patient with pemphigus vulgaris
|
Ng, Z.
|
|
|
30 |
S3 |
p. A38-A39
|
artikel
|
| 50 |
378 Cervical adenocarcinoma. What is the reason for referral?
|
Cervantes, P.
|
|
|
30 |
S3 |
p. A158
|
artikel
|
| 51 |
272 Cervical and endometrial carcinoma in the green lymph node era. pathological findings and management. first experience in argentina with ICG
|
Darin, M.C.
|
|
|
30 |
S3 |
p. A111
|
artikel
|
| 52 |
270 Cervical cancer and human papillomavirus awareness, vaccine status and risk factors among women in Saudi Arabia
|
Akkour, K.
|
|
|
30 |
S3 |
p. A110-A111
|
artikel
|
| 53 |
314 Cervical cancer at the pathology department university hospital center Joseph Ravoahangy Andrianavalona Madagascar
|
Ranaivoson, H.
|
|
|
30 |
S3 |
p. A126-A127
|
artikel
|
| 54 |
298 Cervical cancer in Toamasina, Madagascar
|
Andrianandrasana, N.
|
|
|
30 |
S3 |
p. A122-A123
|
artikel
|
| 55 |
416 Cervical carcinosarcoma with remission of malignant epithelial component but persisting stromal component after radiotherapy – One case report
|
Sun, Y.
|
|
|
30 |
S3 |
p. A173-A174
|
artikel
|
| 56 |
413 Cervical conization and sentinel lymph node for fertility preservation in early low-risk cervical cancer. Less is better?
|
Esteban, A.
|
|
|
30 |
S3 |
p. A171-A172
|
artikel
|
| 57 |
348 Cervical laser vaporization for women with high grade squamous intraepithelial lesion of the cervix
|
Minowa, K.
|
|
|
30 |
S3 |
p. A142
|
artikel
|
| 58 |
274 Characteristics and clinical outcomes of patients with recurrent microsatellite stable endometrial cancer undergoing early phase immunotherapy clinical trials
|
How, J.
|
|
|
30 |
S3 |
p. A112
|
artikel
|
| 59 |
349 Clear cell adenocarcinoma of the peritoneum arising on a background of endometriosis – a rare case
|
Sherring, K.
|
|
|
30 |
S3 |
p. A143
|
artikel
|
| 60 |
436 Clear cell carcinoma in 13 year-old girl with no history of distilben exposure
|
Fertani, Y.
|
|
|
30 |
S3 |
p. A181
|
artikel
|
| 61 |
191 Clinical and pathological characteristics of patients with viloglandular adenocarcinoma of the cervix: a review of 11 cases
|
Marcos, P.R.B.
|
|
|
30 |
S3 |
p. A82-A83
|
artikel
|
| 62 |
210 Clinical and ultrasound characteristics of neuroendocrine tumors of gynaecologic tract
|
Quagliozzi, L.
|
|
|
30 |
S3 |
p. A88-A89
|
artikel
|
| 63 |
153 Clinical auditing as an instrument to improve cancer care: the dutch gynaecological oncology audit (DGOA)
|
Tewarie, N.
|
|
|
30 |
S3 |
p. A67
|
artikel
|
| 64 |
453 Clinical audit on quality of cancer care within the oncological network of piedmont and valle d’aosta: ovarian cancer treatment, interim analysis 2017-2018
|
Laudani, M.
|
|
|
30 |
S3 |
p. A188
|
artikel
|
| 65 |
154 Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients
|
Hasegawa, K.
|
|
|
30 |
S3 |
p. A67-A68
|
artikel
|
| 66 |
35 Clinical management of gynecologic cancer patients during COVID-19 pandemia: the experience of day hospital tumori femminili of fondazione policlinico agostino gemelli, IRCCS
|
Palluzzi, E.
|
|
|
30 |
S3 |
p. A23-A24
|
artikel
|
| 67 |
269 Clinical profiles and intraoperative characteristics after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy– an experience from a tertiary care centre in India
|
Kumar, N.
|
|
|
30 |
S3 |
p. A110
|
artikel
|
| 68 |
418 Clinical translation of methylated DNA markers of endometrial cancer using tampon-based detection
|
Bakkum-Gamez, J.
|
|
|
30 |
S3 |
p. A174-A175
|
artikel
|
| 69 |
328 Clinicopathological significance of FOXL2 and TERT promoter mutations in adult type granulosa cell tumor of the ovary
|
Shoburu, Y.
|
|
|
30 |
S3 |
p. A133
|
artikel
|
| 70 |
42 Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer; development of prediction models using nationwide data
|
Said, S.
|
|
|
30 |
S3 |
p. A28
|
artikel
|
| 71 |
312 Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer
|
Goto, M.
|
|
|
30 |
S3 |
p. A126
|
artikel
|
| 72 |
197 Combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy in stage IVA ovarian carcinoma: a tertiary care centre experience
|
Kumar, N.
|
|
|
30 |
S3 |
p. A84
|
artikel
|
| 73 |
342 Comparative assessment of survival rate in endometrial cancer intermediate risk
|
Mavrichev, S.
|
|
|
30 |
S3 |
p. A139
|
artikel
|
| 74 |
94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer
|
Peters, P.
|
|
|
30 |
S3 |
p. A47
|
artikel
|
| 75 |
287 Comparative study of ovarian low-grade and high-grade serous ovarain carcinoma
|
Mansouri, H.
|
|
|
30 |
S3 |
p. A116-A117
|
artikel
|
| 76 |
441 Comparative study of the HPV impact profile (HIP) interpretation methods in lebanese women with human papilloma virus or associated lesions
|
Atallah, D.
|
|
|
30 |
S3 |
p. A182-A183
|
artikel
|
| 77 |
242 Compared with SARS and MERS, the perinatal outcomes of pregnant women with COVID-19 presented better prognosis based on an updated meta-analysis
|
Huang, X.
|
|
|
30 |
S3 |
p. A99
|
artikel
|
| 78 |
187 Comparing lymph node staging modalities in high risk endometrial cancers: perioperative and long-term clinical outcomes in a community-based comprehensive cancer center
|
Zhang, C.
|
|
|
30 |
S3 |
p. A81
|
artikel
|
| 79 |
208 Comparison of BRCA mutation testing in blood and tumour samples from patients with high grade serous ovarian carcinoma
|
Basha Mohamed, M.
|
|
|
30 |
S3 |
p. A88
|
artikel
|
| 80 |
344 Comparison of clinical pathological and survival outcomes between serous and non-serous ovarian cancer
|
Mansouri, H.
|
|
|
30 |
S3 |
p. A141
|
artikel
|
| 81 |
464 Comparison of different methods to determine myometrial invasion in endometrial cancer – a nationwide SweGCG study
|
Björg, J.
|
|
|
30 |
S3 |
p. A192
|
artikel
|
| 82 |
271 Comparison of genomic instability test scores used for predicting PARP activity in ovarian cancer
|
Timms, K.
|
|
|
30 |
S3 |
p. A111
|
artikel
|
| 83 |
374 Comparison of stage distribution and outcomes of radiotherapy-treated cervical cancer between the international federation of gynecology and obstetrics 2009 and 2018 Staging Systems
|
Tomizawa, K.
|
|
|
30 |
S3 |
p. A156
|
artikel
|
| 84 |
321 Comparison of two types of triple incision technique in the treatment of patients with locally advanced vulvar cancer
|
Wu, M.
|
|
|
30 |
S3 |
p. A129-A130
|
artikel
|
| 85 |
456 Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab
|
Wan Hua, T.
|
|
|
30 |
S3 |
p. A189-A190
|
artikel
|
| 86 |
61 Compliance rate in cervical cancer screening among women living with cervical cancer patient in Jose R. Reyes memorial medical center section of gynecologic oncology
|
Yu, M.
|
|
|
30 |
S3 |
p. A36
|
artikel
|
| 87 |
29 Comprehensive molecular assessment of mismatch repair deficiency in lynch-associated ovarian cancers using next-generation sequencing (NGS) panel
|
Kim, S.
|
|
|
30 |
S3 |
p. A20
|
artikel
|
| 88 |
206 Conditional relative survival of ovarian cancer: a korean national cancer registry study
|
Shin, D.
|
|
|
30 |
S3 |
p. A87
|
artikel
|
| 89 |
104 Conservative surgery in fertility sparing management of early stage cervical cancers – a review of oncologic and reproductive outcomes at a tertiary centre in Australia
|
Chin, F.
|
|
|
30 |
S3 |
p. A50
|
artikel
|
| 90 |
434 Correlation of endometrial tumor DNA mismatch repair status and MELF-pattern invasion
|
DiNobile, C.
|
|
|
30 |
S3 |
p. A180
|
artikel
|
| 91 |
109 Correlation of HPV genotyping, p16 and HPV immunohistochemistry with clinicopathological features in vulval squamous cell carcinomas
|
Basha Mohamed, M.
|
|
|
30 |
S3 |
p. A51
|
artikel
|
| 92 |
244 Cost-effectiveness of preoperative type and screen in patients undergoing laparoscopic hysterectomy
|
Haber, H.
|
|
|
30 |
S3 |
p. A99
|
artikel
|
| 93 |
22 COVID-19: A review of the impact of the pandemic on ovarian cancer patient advocacy organizations from around the world
|
Reid, F.
|
|
|
30 |
S3 |
p. A15-A16
|
artikel
|
| 94 |
465 Delays in treatment in gynaecology oncology patients in qatar seeking management overseas
|
Brich, S.
|
|
|
30 |
S3 |
p. A192
|
artikel
|
| 95 |
200 Demographic characteristics and the clinical profile of vulvar cancer (VC) patients treated at tikur anbessa specialized hospital (TASH)
|
Enoro, E.
|
|
|
30 |
S3 |
p. A85
|
artikel
|
| 96 |
88 Dermatofibrosarcoma protuberans (DFSP) of vulva: case report at pontificia universidad Católica de Chile
|
Pertossi, E.
|
|
|
30 |
S3 |
p. A45-A46
|
artikel
|
| 97 |
325 Dermatomyositis as a paraneoplastic syndrome in high grade serous ovarian carcinoma: a case report and review of literature
|
Hurtado, R.
|
|
|
30 |
S3 |
p. A131-A132
|
artikel
|
| 98 |
440 Desmoid tumor of the breast after mastectomy for breast cancer, a case report
|
Gomez, M.
|
|
|
30 |
S3 |
p. A182
|
artikel
|
| 99 |
69 Detection of ITGBL1 mRNA isoforms in ovarian cancer cells
|
Cortez, A.
|
|
|
30 |
S3 |
p. A39
|
artikel
|
| 100 |
334 Determinants of gynecologic – oncology referral and management of ovarian masses in the philippine general hospital (Preliminary Results of the Overa Study)
|
Velayo, C.
|
|
|
30 |
S3 |
p. A135
|
artikel
|
| 101 |
433 Determining the haematological morbidity associated with cytoreductive surgery
|
Corry, E.
|
|
|
30 |
S3 |
p. A179
|
artikel
|
| 102 |
380 Developing a protocol for pre-operative radiological staging of low-grade endometrial cancer for the thames valley cancer alliance network
|
Smyth, S.
|
|
|
30 |
S3 |
p. A159-A160
|
artikel
|
| 103 |
143 Development and clinical application of a tool to identify frailty in elderly patients with gynecological cancers
|
Ferrero, A.
|
|
|
30 |
S3 |
p. A62-A63
|
artikel
|
| 104 |
39 Development of a nomogram to predict interval debulking surgery feasibility when primary cytoreduction is not an option
|
Rosati, A.
|
|
|
30 |
S3 |
p. A26
|
artikel
|
| 105 |
32 Development of a triage tool including HE4, D-dimer, and fibrinogen for the assessment of women presenting with pelvic masses
|
McKendry, K.
|
|
|
30 |
S3 |
p. A22
|
artikel
|
| 106 |
317 Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer
|
Kurosu, H.
|
|
|
30 |
S3 |
p. A127-A128
|
artikel
|
| 107 |
386 Diagnostic significance of p53, p16, wt1 in lavage samples from uterine cavity for serous ovarian cancer detection
|
Zhordania, K.
|
|
|
30 |
S3 |
p. A161
|
artikel
|
| 108 |
49 2D ICRU-based vs 3D image-guided planning in high dose rate brachytherapy for cervical cancer – a study on efficacy and treatment-related toxicities
|
Faye, M.
|
|
|
30 |
S3 |
p. A31
|
artikel
|
| 109 |
196 Did the cervical cytology screening during pregnancy improve their obstetric and oncologic outcomes of cervical cancer?: A retrospective study
|
Yamazaki, H.
|
|
|
30 |
S3 |
p. A83
|
artikel
|
| 110 |
423 Differential gene expression pattern between preinvasive neoplasia and early invasive cervical carcinoma: putative mechanisms of angiogenesis and epithelial-mesenchymal transition involved in tumor invasion and metastasis
|
Kurmyshkina, O.
|
|
|
30 |
S3 |
p. A176
|
artikel
|
| 111 |
250 Differing risk of ovarian clear cell carcinoma in Asian subpopulations
|
Chow, S.
|
|
|
30 |
S3 |
p. A102
|
artikel
|
| 112 |
460 Diffuse large B-cell lymphoma of the ovary: a series of four cases
|
Ben Hamida, K.
|
|
|
30 |
S3 |
p. A191
|
artikel
|
| 113 |
263 Discordant mismatch repair protein expression in synchronous endometrial and ovarian cancers
|
Kim, S.
|
|
|
30 |
S3 |
p. A107-A108
|
artikel
|
| 114 |
50 Disproportionate incidence of neuroendocrine cervical cancer in minority populations – a study of 2,046 patients
|
Liao, C.
|
|
|
30 |
S3 |
p. A31-A32
|
artikel
|
| 115 |
431 Distant metastatic spread and clonal evolution of high-grade endometrial cancers
|
Miller, K.
|
|
|
30 |
S3 |
p. A179
|
artikel
|
| 116 |
113 Doege – potter syndrome: a rare presentation of pelvic malignant solitary fibrous tumour
|
Sinha, R.
|
|
|
30 |
S3 |
p. A52
|
artikel
|
| 117 |
408 Dose-dense paclitaxel and carboplatin plus bevacizumab is an effective and a tolerable first-line regimen for advanced ovarian cancer
|
Komazaki, H.
|
|
|
30 |
S3 |
p. A169-A170
|
artikel
|
| 118 |
362 Double arm study of performing bowel anastomosis after or before hipec in patients undergoing CRS+ HIPEC for advanced epithelial ovarian cancer
|
Somashekar, S.
|
|
|
30 |
S3 |
p. A149
|
artikel
|
| 119 |
260 Edoxaban anticoagulation for gynecological cancer with venous thromboembolism
|
Odajima, S.
|
|
|
30 |
S3 |
p. A106
|
artikel
|
| 120 |
219 Effect of olaparib treatment on cell cycle, senescence and cell death in ovarian cancer cells
|
Tudrej, P.
|
|
|
30 |
S3 |
p. A91
|
artikel
|
| 121 |
367 Effect of waiting time from pathological diagnosis to definitive concurrent chemoradiation (CCRT) for cervical cancer on overall survival
|
Yeo, H.
|
|
|
30 |
S3 |
p. A150-A152
|
artikel
|
| 122 |
202 Effects of radiological and pathological lymph node status on prognosis in patients with ovarian cancer who underwent interval debulking surgery with lymphadenectomy after neoadjuvant chemotherapy
|
Komatsu, H.
|
|
|
30 |
S3 |
p. A86
|
artikel
|
| 123 |
2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study
|
González-Martín, A.
|
|
|
30 |
S3 |
p. A1-A2
|
artikel
|
| 124 |
18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
|
Harter, P.
|
|
|
30 |
S3 |
p. A13-A14
|
artikel
|
| 125 |
13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)
|
Graybill, W.
|
|
|
30 |
S3 |
p. A10
|
artikel
|
| 126 |
184 Endodermal sinus tumor of the ovary in a twenty-years-old young woman
|
Silveira, V.
|
|
|
30 |
S3 |
p. A80
|
artikel
|
| 127 |
411 Endometrial adenocarcinoma arising from adenomyosis: an unusual case
|
Ortega, M.
|
|
|
30 |
S3 |
p. A171
|
artikel
|
| 128 |
168 Endometrial and colon cancer risk assessment in women with lynch syndrome: provider comfort, knowledge, and current practice
|
Bramblet, R.
|
|
|
30 |
S3 |
p. A73-A74
|
artikel
|
| 129 |
279 Endometrial cancer: initial results of conservative hormonal treatment in postmenopausal patients in oncology hospitals of Buenos Aires
|
Soderini, P.
|
|
|
30 |
S3 |
p. A114
|
artikel
|
| 130 |
25 Endometrial cancer: laparoscopy vs robotic surgery. A large single-institution retrospective analysis
|
Perrone, E.
|
|
|
30 |
S3 |
p. A17
|
artikel
|
| 131 |
98 Endometrial cancer: the role of prognostic factors and their impact on recurrence pattern
|
Parpinel, G.
|
|
|
30 |
S3 |
p. A48
|
artikel
|
| 132 |
164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer
|
Lorusso, D.
|
|
|
30 |
S3 |
p. A71
|
artikel
|
| 133 |
323 ENGOT-en9/LEAP-001: a phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer
|
Randall, L.
|
|
|
30 |
S3 |
p. A130
|
artikel
|
| 134 |
118 Epidemiology of cervical cancer in the republic of Belarus
|
Matylevich, O.
|
|
|
30 |
S3 |
p. A54
|
artikel
|
| 135 |
455 Epidemiology of endometrium cancer in Belarus
|
Shushkevich, A.
|
|
|
30 |
S3 |
p. A189
|
artikel
|
| 136 |
387 Estrogen-related receptor alpha (ESRRA) copy number variation is associated with histological grade in ovarian cancer
|
Huang, X.
|
|
|
30 |
S3 |
p. A161
|
artikel
|
| 137 |
78 Evaluation changes in indicators of oncological service in cervix uteri cancer in Kazakhstan
|
Kukubassov, Y.
|
|
|
30 |
S3 |
p. A42
|
artikel
|
| 138 |
137 Evidence based ESMO-ESGO-ESTRO endometrial cancer guidelines: are adequate for planning adjuvant therapy?
|
Fuso, L.
|
|
|
30 |
S3 |
p. A60-A61
|
artikel
|
| 139 |
343 External validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer undergoing primary surgery
|
Bizzarri, N.
|
|
|
30 |
S3 |
p. A140-A141
|
artikel
|
| 140 |
252 Extra ovarian endodermal sinus tumour diagnosed at caesarean section
|
West, S.
|
|
|
30 |
S3 |
p. A103
|
artikel
|
| 141 |
471 Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy
|
Corinti, M.
|
|
|
30 |
S3 |
p. A195
|
artikel
|
| 142 |
350 Factors associated with acute kidney injury in patients undergoing open gynecologic surgery on an enhanced recovery after surgery pathway
|
Huepenbecker, S.
|
|
|
30 |
S3 |
p. A143
|
artikel
|
| 143 |
237 Fallopian tube choriocarcinoma: a case report
|
Peshkova, T.
|
|
|
30 |
S3 |
p. A97
|
artikel
|
| 144 |
442 Familial swyer syndrome associated with mixed germ cell tumor: a case report
|
David, M.
|
|
|
30 |
S3 |
p. A183
|
artikel
|
| 145 |
330 Firstline maintenance parp inhibitors in advanced ovarian cancer: a network meta-analysis for comparative efficacy and adverse events
|
Haddad, P.
|
|
|
30 |
S3 |
p. A133-A134
|
artikel
|
| 146 |
9 Frailty is independently associated with worse outcomes and increased resource use following procedures to treat endometrial cancer
|
Nakhla, M.
|
|
|
30 |
S3 |
p. A7
|
artikel
|
| 147 |
379 Frequency and molecular associations of KRAS mutations in gynecologic malignancies
|
Kilowski, K.
|
|
|
30 |
S3 |
p. A158-A159
|
artikel
|
| 148 |
220 Functional analysis of ZFHX4 as a novel therapeutic target in ovarian cancer
|
Oyama, Y.
|
|
|
30 |
S3 |
p. A91
|
artikel
|
| 149 |
366 Genomic profile of clear cell ovarian cancers and evolution with disease progression
|
Mesnage, S.
|
|
|
30 |
S3 |
p. A150
|
artikel
|
| 150 |
198 Germline and somatic BRCA1/2 gene mutational status and clinical outcomes in epithelial peritoneal, ovarian, and fallopian tube cancer
|
Kim, S.
|
|
|
30 |
S3 |
p. A84
|
artikel
|
| 151 |
86 Gliomatosis peritonei associated with ovarian germ cell tumours- a clinicopathological case series
|
Jayraj, A.
|
|
|
30 |
S3 |
p. A45
|
artikel
|
| 152 |
357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial
|
Wu, X.
|
|
|
30 |
S3 |
p. A147
|
artikel
|
| 153 |
76 Granular cell tumor, a rare breast tumor
|
Gomez, M.
|
|
|
30 |
S3 |
p. A42
|
artikel
|
| 154 |
277 Gynaefellow’: a new online multi-media resource for gynae-oncology & gynaecology surgery training
|
Alazzam, M.
|
|
|
30 |
S3 |
p. A113
|
artikel
|
| 155 |
85 Gynecological cancers seen in the oncology units of the joseph ravoahangy andrianavalona hospital, Antananarivo, Madagascar
|
Andrianandrasana, N.
|
|
|
30 |
S3 |
p. A44
|
artikel
|
| 156 |
233 Gynecological malignancies in emergency department
|
Onishi, Y.
|
|
|
30 |
S3 |
p. A96
|
artikel
|
| 157 |
238 Gynecologic oncology at the time of SARS-CoV-2 (COVID-19) outbreak
|
Bogani, G.
|
|
|
30 |
S3 |
p. A97-A98
|
artikel
|
| 158 |
316 High grade transformation of low-grade endometrial stromal sarcoma; a morphological, immunohistochemical and molecular case study
|
Ralte, A.
|
|
|
30 |
S3 |
p. A127
|
artikel
|
| 159 |
222 High incidence of venous thromboembolism in patients receiving neoadjuvant chemotherapy for advanced stage ovarian cancer
|
Chokshi, S.
|
|
|
30 |
S3 |
p. A92
|
artikel
|
| 160 |
189 High-resolution spatial analysis of the tumour microenvironment of high grade serous ovarian cancer (HGSOC) using single cell transcriptomics
|
Lim, J.
|
|
|
30 |
S3 |
p. A82
|
artikel
|
| 161 |
319 High tumor-stroma ratio in estrogen receptor-positive breast cancer is correlated to poor histopathological parameters
|
Bacha, D.
|
|
|
30 |
S3 |
p. A128
|
artikel
|
| 162 |
267 Histopathologic ultrastaging of sentinel lymph nodes in endometrial carcinoma: A retrospective analysis of the tuebingen women’s hospital 2006-2016 patient cohort
|
Baudoux, L.
|
|
|
30 |
S3 |
p. A109-A110
|
artikel
|
| 163 |
134 HRT is not detrimental to survival in women diagnosed with stage 1B–2B (FIGO 2009) adenocarcinomas of the cervix aged less than 50
|
Richardson, A.
|
|
|
30 |
S3 |
p. A59-A60
|
artikel
|
| 164 |
171 Human papillomavirus genotype and long-term clinical outcomes of vulvar malignancies
|
Tung, H.
|
|
|
30 |
S3 |
p. A75
|
artikel
|
| 165 |
193 Hydronephrosis in cervical cancer patients in Antananarivo, Madagascar
|
Razanadahy, T.
|
|
|
30 |
S3 |
p. A83
|
artikel
|
| 166 |
43 Hyperprogression of choriocarcinoma after treatment with pembrolizumab
|
Yeganeh Kazemi, N.
|
|
|
30 |
S3 |
p. A28-A29
|
artikel
|
| 167 |
136 Hyperthermic intraperitoneal chemotherapy for gynecologic malignancies in a community-based comprehensive cancer center: A review of morbidity and experience
|
Meelheim, B.
|
|
|
30 |
S3 |
p. A60
|
artikel
|
| 168 |
429 Identification of clinicopathological prognostic factors in recurrent endometrial cancer
|
Koike, Y.
|
|
|
30 |
S3 |
p. A178
|
artikel
|
| 169 |
114 Identification of factors impacting recurrence in patients treated for borderline ovarian tumors: a focus on radicality and minimally-invasive approach
|
Longo, M.
|
|
|
30 |
S3 |
p. A52-A53
|
artikel
|
| 170 |
45 Immune cell profiling may predict clinical outcomes in uterine leiomyosarcoma
|
Fujii, T.
|
|
|
30 |
S3 |
p. A30
|
artikel
|
| 171 |
398 Impact of a laparoscopic triage program for advanced ovarian cancer on surgical outcomes, disease-free survival, and overall survival
|
Mulder, I.
|
|
|
30 |
S3 |
p. A165
|
artikel
|
| 172 |
23 Impact of COVID-19 in gynecologic oncology: a nationwide Italian survey
|
Bogani, G.
|
|
|
30 |
S3 |
p. A16
|
artikel
|
| 173 |
405 Impact of hyperthermic intraperitoneal chemotherapy (HIPEC) on tumor microenvironment (TME) in ovarian cancer – a subanalysis from a Phase I clinical trial
|
Dellinger, T.
|
|
|
30 |
S3 |
p. A168-A169
|
artikel
|
| 174 |
265 Impact of mismatch repair protein and PD-L1 expression for therapeutic stratification in Japanese ovarian clear cell carcinoma
|
Kawabata, A.
|
|
|
30 |
S3 |
p. A108
|
artikel
|
| 175 |
318 Impact of the SARS-CoV2 pandemic on the clinical and research management of patients with gynecological malignancies: an ongoing survey in the Pan-Arabian region
|
Nasser, S.
|
|
|
30 |
S3 |
p. A128
|
artikel
|
| 176 |
445 Improving women’s health – one humanpapillomavirus vaccination at a time!
|
Ang, J.
|
|
|
30 |
S3 |
p. A184-A185
|
artikel
|
| 177 |
254 Incidence of leiomyosarcoma after the FDA warning against the power morcellator – have we made an impact?
|
Liao, C.
|
|
|
30 |
S3 |
p. A103-A104
|
artikel
|
| 178 |
75 Incidence of lymph node metastasis in apparent early stage endometrioid ovarian carcinoma
|
Nasioudis, D.
|
|
|
30 |
S3 |
p. A41-A42
|
artikel
|
| 179 |
141 Increased incidence of cervical adenosquamous cell carcinoma in minority populations
|
Liao, C.
|
|
|
30 |
S3 |
p. A61-A62
|
artikel
|
| 180 |
41 Increase in uterine serous carcinoma: will it surpass uterine endometrioid cancer? A population analysis of 720,984 uterine cancer patients
|
Liao, C.
|
|
|
30 |
S3 |
p. A27-A28
|
artikel
|
| 181 |
299 Increasing incidence of sex cord-stromal tumors in the United States
|
Ratnaparkhi, R.
|
|
|
30 |
S3 |
p. A123
|
artikel
|
| 182 |
57 Indocyanine green compared to technetium-99m and blue dye in the detection of sentinel lymph nodes in early stage cervical cancer: a systematic review and meta-analysis
|
Baeten, I.
|
|
|
30 |
S3 |
p. A34
|
artikel
|
| 183 |
294 Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19
|
Smith, M.
|
|
|
30 |
S3 |
p. A120
|
artikel
|
| 184 |
128 In silico analysis of the immune checkpoint TIGIT as a novel immunotherapy target for high grade serous ovarian cancer
|
Glennon, K.
|
|
|
30 |
S3 |
p. A57
|
artikel
|
| 185 |
40 Integrated model of patient factors, resectability score and surgical complexity index to predict surgical outcome in debulking surgery for advanced ovarian cancer
|
Hogen, L.
|
|
|
30 |
S3 |
p. A26-A27
|
artikel
|
| 186 |
255 Interobserver variability of breast grading in core biopsies
|
Bacha, D.
|
|
|
30 |
S3 |
p. A104
|
artikel
|
| 187 |
266 Intra-epithelial spreading of cervical squamous cell carcinoma to the upper genital tract
|
Shi, X.
|
|
|
30 |
S3 |
p. A108-A109
|
artikel
|
| 188 |
352 Intra-operative frozen section examination of pelvic lymph nodes in early cervical cancer
|
Jackson, E.
|
|
|
30 |
S3 |
p. A145
|
artikel
|
| 189 |
201 Intra-tumoural electro-chemotherapy (ECT) with bleomycin for palliation of cutaneous recurrence in gynaecological malignancy
|
Rundle, S.
|
|
|
30 |
S3 |
p. A85
|
artikel
|
| 190 |
303 Intravenous leiomyomatosis
|
Stilidi, I.
|
|
|
30 |
S3 |
p. A123-A124
|
artikel
|
| 191 |
336 Is a vaginectomy enough or is a pelvic exenteration always required for surgical treatment of recurrent cervical cancer?
|
Vizzielli, G.
|
|
|
30 |
S3 |
p. A136
|
artikel
|
| 192 |
417 KRAS mutant uterine carcinomas
|
Kilowski, K.
|
|
|
30 |
S3 |
p. A174
|
artikel
|
| 193 |
145 KRAS mutation may be one of the chemo-resistant phenotype of ovarian clear cell carcinoma
|
Konno, Y.
|
|
|
30 |
S3 |
p. A63
|
artikel
|
| 194 |
472 Laparoscopic approach for cervical or vaginal malignancies in patients with previous histerectomy. A report of three cases
|
Darin, M.C.
|
|
|
30 |
S3 |
p. A195
|
artikel
|
| 195 |
481 Laparoscopic approach to bulky pelvic lymph nodes: tips and ticks
|
Ribeiro, R.
|
|
|
30 |
S3 |
p. A198
|
artikel
|
| 196 |
157 Laparoscopic approach to comprehensive surgical staging for clinical stage I endometrial cancer: an institutional review of operative outcomes, costs and its clinical implications
|
Facun, G.
|
|
|
30 |
S3 |
p. A69
|
artikel
|
| 197 |
485 Laparoscopic assisted infralevator posterior exenteration with vulvovaginal reconstruction
|
Shylasree, T.S.
|
|
|
30 |
S3 |
p. A199
|
artikel
|
| 198 |
466 Laparoscopic management of huge ovarian cyst; novel technique
|
Addley, S.
|
|
|
30 |
S3 |
p. A193
|
artikel
|
| 199 |
484 Laparoscopic nerve sparing radical hysterectomy: Measure to prevent tumor spillage for better prognosis and preservation of voiding function based on clinical pelvic anatomy
|
Shiki, Y.
|
|
|
30 |
S3 |
p. A199
|
artikel
|
| 200 |
469 Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy
|
Choi, J.S.
|
|
|
30 |
S3 |
p. A194
|
artikel
|
| 201 |
470 Laparoscopic resection of bulky para-aortic lymph node metastasis
|
Choi, J.S.
|
|
|
30 |
S3 |
p. A194-A195
|
artikel
|
| 202 |
315 Laparoscopic sentinel node biopsy in early endometrial cancer using indocyanine green: a report of the first two cases in the philippines
|
Yap, B.
|
|
|
30 |
S3 |
p. A127
|
artikel
|
| 203 |
89 Large cell neuroendocrine carcinoma (LCNEC) of the endometrium : case report at hospital Sótero Del Río, Chile
|
Pertossi, E.
|
|
|
30 |
S3 |
p. A46
|
artikel
|
| 204 |
172 Late effects on rectum and urinary bladder in cervical cancer brachytherapy: dose effect relationship and ICRU rectum and bladder point dose correlation
|
Mathews, S.
|
|
|
30 |
S3 |
p. A75
|
artikel
|
| 205 |
468 Laterally extended parametrectomy (LEP)
|
Capilna, M.
|
|
|
30 |
S3 |
p. A194
|
artikel
|
| 206 |
407 Leiomyoma with bizarre nuclei: clinical and pathologic features of 10 patients
|
Bacha, D.
|
|
|
30 |
S3 |
p. A169
|
artikel
|
| 207 |
320 LncRNA NEAT1-mediated miR-361 downregulation contributes to EMT and sphere formation of cervical cancer cells via increasing HSP90 expression
|
Dong, P.
|
|
|
30 |
S3 |
p. A128-A129
|
artikel
|
| 208 |
393 Long-term neurological side effects in long-term survivors with ovarian cancer
|
El Ouardi, N.
|
|
|
30 |
S3 |
p. A163
|
artikel
|
| 209 |
20 Long-term survival outcomes of intravenous vs intraperitoneal chemotherapy in the treatment of advanced ovarian cancer
|
Kim, R.
|
|
|
30 |
S3 |
p. A15
|
artikel
|
| 210 |
335 Low BRCA 1/2 germline mutation rate in a french canadian population
|
Bernard, J.
|
|
|
30 |
S3 |
p. A136
|
artikel
|
| 211 |
463 LVSI and Ki67 in prediction of lymph-node metastasis in primary low-grade ovarian cancer
|
Grabowski, J.
|
|
|
30 |
S3 |
p. A191-A192
|
artikel
|
| 212 |
430 Machine learning models to predict survival outcomes after radical hysterectomy according to surgical approach in patients with FIGO stage IB cervical cancer
|
Kim, S.
|
|
|
30 |
S3 |
p. A178-A179
|
artikel
|
| 213 |
293 Malignant transformations in mature cystic teratoma of the ovary. ‘rare, rarer, rarest’
|
Billod, J.
|
|
|
30 |
S3 |
p. A119
|
artikel
|
| 214 |
364 Management of benign metastasizing leiomyoma: a report of three cases
|
Inoue, K.
|
|
|
30 |
S3 |
p. A149-A150
|
artikel
|
| 215 |
404 Mesonephric adenocarcinoma; a case report and review of the literature
|
Daas, M.
|
|
|
30 |
S3 |
p. A167
|
artikel
|
| 216 |
26 Meta-analysis comparing influence of no adjuvant treatment, postoperative radiotherapy and/or chemotherapy on survival in patients after primary surgery including lymphadenectomy for early stage uterine carcinosarcoma
|
Student, V.
|
|
|
30 |
S3 |
p. A17-A18
|
artikel
|
| 217 |
83 Metastatic melanoma in the breast : a report of 7 cases
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A44
|
artikel
|
| 218 |
205 Minimally invasive approaches in locally advanced cervical cancer patients undergoing radical surgery after chemoradiotherapy: a propensity score analysis
|
Gallotta, V.
|
|
|
30 |
S3 |
p. A86-A87
|
artikel
|
| 219 |
482 Minimally invasive bleeding management during pelvic lymphadenectomy
|
Ribeiro, R.
|
|
|
30 |
S3 |
p. A198
|
artikel
|
| 220 |
249 Minimally invasive surgery improves overall survival for endometrial cancer
|
Carbajal-Mamani, S.
|
|
|
30 |
S3 |
p. A102
|
artikel
|
| 221 |
123 Minimally invasive surgery versus laparotomy in HGS EOC patients in a teaching referral center
|
Ribeiro, B.
|
|
|
30 |
S3 |
p. A55-A56
|
artikel
|
| 222 |
44 Minimally invasive surgical staging for early stage ovarian cancer: a long term follow up
|
Gallotta, V.
|
|
|
30 |
S3 |
p. A29
|
artikel
|
| 223 |
304 Minimally invasive versus open radical hysterectomy for stage IB2 cervical carcinoma; an updated survival analysis of the national cancer database
|
Nasioudis, D.
|
|
|
30 |
S3 |
p. A124
|
artikel
|
| 224 |
235 Mode of presentation and factors associated with late clinical presentation of cervical cancer in komfo anokye teaching hospital (KATH)
|
Appiah-kubi, A.
|
|
|
30 |
S3 |
p. A96-A97
|
artikel
|
| 225 |
33 Molecular subtype diagnosis of endometrial carcinoma: comparison of NGS panel and promise classifier
|
Huvila, J.
|
|
|
30 |
S3 |
p. A22-A23
|
artikel
|
| 226 |
359 Mortality trends in gynecological cancers in Chile
|
Brañes, J.
|
|
|
30 |
S3 |
p. A148
|
artikel
|
| 227 |
58 Multidisciplinary surgical approach to increase complete cytoreduction rates for advanced ovarian cancer in a tertiary gynaecological oncology centre
|
Mulligan, K.
|
|
|
30 |
S3 |
p. A34-A35
|
artikel
|
| 228 |
132 Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer
|
Khaldi, H.
|
|
|
30 |
S3 |
p. A59
|
artikel
|
| 229 |
309 Neo-adjuvant chemotherapy for cervical cancer during pregnancy: a retrospective case series
|
Lopez, A.
|
|
|
30 |
S3 |
p. A125-A126
|
artikel
|
| 230 |
71 Neoadjuvant chemotherapy in epithelial ovarian cancer: a case-control study in a Lebanese tertiary care center
|
Atallah, D.
|
|
|
30 |
S3 |
p. A40
|
artikel
|
| 231 |
102 Neoadjuvant chemotherapy with uterine artery chemoembolization in the management of locally advanced cervical cancer: belarus experience
|
Matylevich, O.
|
|
|
30 |
S3 |
p. A49
|
artikel
|
| 232 |
240 Nerve sparing radical hysterectomy; muallem technique with a precise explanation of parametrium and paracolpium
|
Muallem, M.
|
|
|
30 |
S3 |
p. A98
|
artikel
|
| 233 |
166 Nerve sparing radical hysterectomy with a precise definition of parametrium and paracolpium: short-term oncologic, surgical and functional outcomes
|
Muallem, M.
|
|
|
30 |
S3 |
p. A72-A73
|
artikel
|
| 234 |
313 No more frozen section for preoperative diagnoses of atypical endometrial hyperplasia
|
Almeida, J.
|
|
|
30 |
S3 |
p. A126
|
artikel
|
| 235 |
158 Non-epithelial ovarian tumors: A single institute retrospective study
|
de Sá, I.
|
|
|
30 |
S3 |
p. A69
|
artikel
|
| 236 |
214 No socioeconomic differences in overall survival seen in patients with advanced ovarian cancer where parity of access to treatment and cytoreductive outcomes can be achieved
|
Watson, L.
|
|
|
30 |
S3 |
p. A89-A90
|
artikel
|
| 237 |
284 Obesity and type I endometrial carcinoma: an overly simplified model?
|
Liao, C.
|
|
|
30 |
S3 |
p. A115
|
artikel
|
| 238 |
174 Obesity and visceral fat: survival impact in endometrial cancer
|
Donkers, H.
|
|
|
30 |
S3 |
p. A75-A76
|
artikel
|
| 239 |
101 Oncological outcomes following risk reducing bilateral salpingo-oophorectomy in women deemed high risk for ovarian cancer
|
Smallwood, K.
|
|
|
30 |
S3 |
p. A48-A49
|
artikel
|
| 240 |
207 Oncological outcomes of minimally invasive radical hysterectomy versus radical abdominal hysterectomy in patients with early stage cervical cancer: a multicenter retrospective analysis
|
Rodriguez, J.
|
|
|
30 |
S3 |
p. A87
|
artikel
|
| 241 |
11 Oncologic outcomes and role of adjuvant therapy in endometrial cancer patients with low volume metastasis in the sentinel lymph nodes: an international multi-institutional study
|
Ghoniem, K.
|
|
|
30 |
S3 |
p. A8
|
artikel
|
| 242 |
12 Oncolytic vaccinia (Olvi-Vec) primed immunochemotherapy in platinum-resistant/refractory ovarian cancer
|
Holloway, R.
|
|
|
30 |
S3 |
p. A9-A10
|
artikel
|
| 243 |
302 Opportunistic assessment of bone mineral density on computed tomography in the gynaecological oncology setting
|
O’Gorman, C.
|
|
|
30 |
S3 |
p. A123
|
artikel
|
| 244 |
450 Orbital metastasis of breast carcinoma: a series of five cases
|
Ben Hamida, K.
|
|
|
30 |
S3 |
p. A187
|
artikel
|
| 245 |
306 Outcomes after the regionalization of care for high risk endometrial cancers: a population-based study
|
Nica, A.
|
|
|
30 |
S3 |
p. A125
|
artikel
|
| 246 |
133 Outcomes of minimally invasive staging for clinical stage I ovarian clear cell carcinoma
|
Nasioudis, D.
|
|
|
30 |
S3 |
p. A59
|
artikel
|
| 247 |
347 Outcomes of patients undergoing extremely high complexity surgery (EHCS) for advanced ovarian cancer, a single centre review of practice
|
Watson, L.
|
|
|
30 |
S3 |
p. A142
|
artikel
|
| 248 |
339 Ovarian cancer epidemiology in Jigawa, Nigeria. A 4 year review
|
Adejumo, R.
|
|
|
30 |
S3 |
p. A138
|
artikel
|
| 249 |
458 Ovarian cancer statistics in Kazakhstan for 2004-2019 years
|
Kaidarova, D.
|
|
|
30 |
S3 |
p. A190
|
artikel
|
| 250 |
144 Ovarian carcinoma long-term survivors: a large single center study at the tübingen university women’s hospital
|
Mittelstadt, S.
|
|
|
30 |
S3 |
p. A63
|
artikel
|
| 251 |
368 Ovarian sertoli-leydig tumors : epidemiological and prognostic features
|
Kaabia, O.
|
|
|
30 |
S3 |
p. A152
|
artikel
|
| 252 |
19 Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study
|
Garzon, S.
|
|
|
30 |
S3 |
p. A14-A15
|
artikel
|
| 253 |
241 Palbociclib in the daily clinical use: real experience in metastatic breast cancer in our institution
|
Mainella, A.
|
|
|
30 |
S3 |
p. A98-A99
|
artikel
|
| 254 |
435 Palliative electrochemotherapy in vulvar cancer: a double institution study and review of the literature
|
Corrado, G.
|
|
|
30 |
S3 |
p. A180-A181
|
artikel
|
| 255 |
389 Papillary carcinoma in the breast of the male : Report of 3 cases
|
Bouraoui, I.
|
|
|
30 |
S3 |
p. A162
|
artikel
|
| 256 |
268 Papillary carcinoma of the breast : report of 30 cases
|
Bouraoui, I.
|
|
|
30 |
S3 |
p. A110
|
artikel
|
| 257 |
356 Papillary squamous carcinoma of the cervix with metachronous clear cell renal cell carcinoma
|
Medalla, R.
|
|
|
30 |
S3 |
p. A146-A147
|
artikel
|
| 258 |
221 Paraaortic lymphadenectomy in cervical cancer stage IIIC1r international federation of gynecology and obstetrics 2018: experience at the instituto nacional de cancerología
|
Acosta, J.
|
|
|
30 |
S3 |
p. A91-A92
|
artikel
|
| 259 |
443 Participant demographics and disparities in ovarian cancer clinical trials
|
Howell, E.
|
|
|
30 |
S3 |
p. A183-A184
|
artikel
|
| 260 |
384 Patient initiated follow up: experiences from a tertiary gynaecological oncology centre
|
Fairley, H.
|
|
|
30 |
S3 |
p. A160
|
artikel
|
| 261 |
332 Patterns of care and outcomes of vulvar cancer treatment in women with or without HIV infection in Botswana
|
Sakamuri, S.
|
|
|
30 |
S3 |
p. A134-A135
|
artikel
|
| 262 |
425 Patterns of recurrence in low-risk endometrial cancer- evidence for a change in follow-up
|
Naaman, Y.
|
|
|
30 |
S3 |
p. A177
|
artikel
|
| 263 |
24 Patterns of recurrence in vulvar cancer: a nationwide population-based study
|
Zach, D.
|
|
|
30 |
S3 |
p. A16-A17
|
artikel
|
| 264 |
149 Pelvic lymphadenectomy in vulvar squamous-cell cancer- a monocentric study of the relation between lymph-node involvement of groin and pelvis at the university medical center Hamburg
|
Jaeger, A.
|
|
|
30 |
S3 |
p. A65
|
artikel
|
| 265 |
340 Performance characteristics of screening strategies to identify Lynch syndrome in women with non-serous and non-mucinous ovarian cancer
|
Kim, S.
|
|
|
30 |
S3 |
p. A138-A139
|
artikel
|
| 266 |
409 Perioperative complications after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) – an experience from the tertiary care centre in North India
|
Kumar, N.
|
|
|
30 |
S3 |
p. A170
|
artikel
|
| 267 |
278 Personalization of the treatment in patients with endometrial cancer and life-threatening comorbidities
|
Dikareva, E.
|
|
|
30 |
S3 |
p. A113-A114
|
artikel
|
| 268 |
138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC)
|
Naumann, R.
|
|
|
30 |
S3 |
p. A61
|
artikel
|
| 269 |
14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
|
Nishikawa, N.
|
|
|
30 |
S3 |
p. A10-A11
|
artikel
|
| 270 |
369 Phase II trial on the feasibility of single dose intraoperative normothermic intraperitoneal carboplatin (NIPEC) in advanced epithelial ovarian cancer following optimal cytoreductive surgery
|
Shivdas, S.
|
|
|
30 |
S3 |
p. A152
|
artikel
|
| 271 |
358 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-ov50/GOG-329/INNOVATE-3
|
Vergote, I.
|
|
|
30 |
S3 |
p. A147-A148
|
artikel
|
| 272 |
391 Positive surgical margin is an independent predictor of overall survival of patients with vulvar squamous carcinoma
|
Nomura, H.
|
|
|
30 |
S3 |
p. A163
|
artikel
|
| 273 |
395 Post-cone residual disease in microinvasive cervical cancer: importance of surgical margin
|
Cervantes, P.
|
|
|
30 |
S3 |
p. A164
|
artikel
|
| 274 |
3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations
|
Weberpals, J.
|
|
|
30 |
S3 |
p. A2-A3
|
artikel
|
| 275 |
119 Postradiation cutaneous angiosarcoma after treatment of breast carcinoma
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A54
|
artikel
|
| 276 |
97 Practicing knowledge translation: building awareness and assessing barriers and facilitators to provincial implementation of the proactive molecular risk classifier for endometrial cancer (ProMisE)
|
Prestley, N.
|
|
|
30 |
S3 |
p. A48
|
artikel
|
| 277 |
161 Prediction of ovarian cancer using a multivariate assay: a randomized controlled trial to improve diagnostic strategies in filipino women (preliminary results of the overa study)
|
Velayo, C.
|
|
|
30 |
S3 |
p. A70-A71
|
artikel
|
| 278 |
228 Predictive factors of lymph node involvement and topography of lymph node metastasis in patients with epithelial ovarian cancer
|
Atallah, D.
|
|
|
30 |
S3 |
p. A94
|
artikel
|
| 279 |
459 Predictive factors of para aortic lymph node invasion in epithelial ovarian cancer
|
Mansouri, H.
|
|
|
30 |
S3 |
p. A190
|
artikel
|
| 280 |
396 Predictive factors of survival and recurrence in patients with epithelial ovarian cancer after complete cytoreductive surgery: series of 185 patients
|
Atallah, D.
|
|
|
30 |
S3 |
p. A164-A165
|
artikel
|
| 281 |
462 Predictive radiogenomic model based on ovarian ultrasound images to detect germline brca 1-2 status (probe study) a radiogenomic model on us images
|
Nero, C.
|
|
|
30 |
S3 |
p. A191
|
artikel
|
| 282 |
251 Pregnancy management during thyroid cancer in post chernobyl area
|
Shushkevich, A.
|
|
|
30 |
S3 |
p. A102-A103
|
artikel
|
| 283 |
262 Pre-operative wait times in high risk endometrial cancer: do surgical delays impact patient survival?
|
Nica, A.
|
|
|
30 |
S3 |
p. A107
|
artikel
|
| 284 |
28 Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in the combined PORTEC-1,-2 and -3 endometrial cancer trials
|
Post, C.
|
|
|
30 |
S3 |
p. A20
|
artikel
|
| 285 |
421 Prevalence of cachexia in treatment-naïve patients with gynaecological cancer: a systematic review
|
O’Donoghue, N.
|
|
|
30 |
S3 |
p. A176
|
artikel
|
| 286 |
322 Prevalence of hrHPV DNA and p16/ki67 expression among women with cervical dysplasia
|
Sekar, A.
|
|
|
30 |
S3 |
p. A130
|
artikel
|
| 287 |
275 Prevalence of uterine sarcomas in the oncological gynecology unit of the san borja arriaran hospital
|
Cervantes, P.
|
|
|
30 |
S3 |
p. A112-A113
|
artikel
|
| 288 |
62 Primary breast lymphoma: a report of 13 cases and revue of literature
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A36-A37
|
artikel
|
| 289 |
439 Primary symptoms in women with different histopathological subtypes of gynaecological sarcoma – results of a prospective intergroup registry for gynaecological sarcoma (REGSA – NOGGO RU1)
|
Roser, E.
|
|
|
30 |
S3 |
p. A182
|
artikel
|
| 290 |
307 Primitive carcinoma of the fallopian tube: clinical and prognostic features
|
Kaabia, O.
|
|
|
30 |
S3 |
p. A125
|
artikel
|
| 291 |
67 Problem solving using the A3 methodology for colposcopy
|
Vemanamandhi, P.
|
|
|
30 |
S3 |
p. A37-A38
|
artikel
|
| 292 |
415 Prognostic factors for recurrence in carcinoma endometrium
|
Prakasan, A.
|
|
|
30 |
S3 |
p. A173
|
artikel
|
| 293 |
256 Prognostic factors of survival and recurrence of paget’s disease of the breast: a study of 58 cases
|
Mansouri, H.
|
|
|
30 |
S3 |
p. A104
|
artikel
|
| 294 |
414 Prognostic factors related to recurrence and survival of early stage vulvar squamous cell carcinoma
|
Wang, Y.
|
|
|
30 |
S3 |
p. A173
|
artikel
|
| 295 |
146 Prognostic significance of histologic squamous metaplasia and immunohistochemical staining patterns of β-catenin and p53 in biopsy-proven endometrial intraepithelial neoplasia
|
Wong, J.
|
|
|
30 |
S3 |
p. A63-A64
|
artikel
|
| 296 |
130 Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer
|
Mansouri, H.
|
|
|
30 |
S3 |
p. A58
|
artikel
|
| 297 |
36 Prognostic value and association with veliparib benefit of modeled CA-125 elimination kinetics (KELIM) in patients with newly diagnosed ovarian cancer: analysis from the VELIA/GOG-3005 study
|
You, B.
|
|
|
30 |
S3 |
p. A24-A25
|
artikel
|
| 298 |
155 Prognostic value and therapeutic implications of pleural carcinosis and malignant pleural effusion in advanced epithelial ovarian cancer
|
Nasser, S.
|
|
|
30 |
S3 |
p. A68
|
artikel
|
| 299 |
54 Prognostic value of p53 protein expression in breast cancer
|
Ben Slama, S.
|
|
|
30 |
S3 |
p. A33
|
artikel
|
| 300 |
273 Project echo: 2-years experience in Belarus
|
Matylevich, O.
|
|
|
30 |
S3 |
p. A112
|
artikel
|
| 301 |
428 Prospective evaluation of an ERAS pathway at a gynaecological oncology unit in oslo, norway
|
Lindemann, K.
|
|
|
30 |
S3 |
p. A178
|
artikel
|
| 302 |
365 Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy for advanced ovarian, fallopian tube and primary peritoneal cancer patients
|
Nomura, H.
|
|
|
30 |
S3 |
p. A150
|
artikel
|
| 303 |
373 Protective role of conization before radical hysterectomy in early-stage cervical cancer: a propensity-score matching study
|
Bizzarri, N.
|
|
|
30 |
S3 |
p. A154-A156
|
artikel
|
| 304 |
361 Psoas muscle volume is predictive factor for poor survival in elderly ovarian cancer patients
|
Tomita, Y.
|
|
|
30 |
S3 |
p. A148-A149
|
artikel
|
| 305 |
326 Pure tubular carcinoma of the breast: a rare entity
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A132-A133
|
artikel
|
| 306 |
16 Quality-adjusted (QA) progression-free survival analyses of veliparib + carboplatin/paclitaxel (CP) vs CP alone in patients with newly diagnosed ovarian cancer
|
Alvarez Secord, A.
|
|
|
30 |
S3 |
p. A12
|
artikel
|
| 307 |
383 Quality of life concerns during and after treatment for advanced breast or cervical cancer in Zambia
|
Pfaendler, K.
|
|
|
30 |
S3 |
p. A160
|
artikel
|
| 308 |
37 Quantitative evaluation of lymph-vascular space invasion (LVSI) in patients affected by endometrial cancer: prognostic and clinical implications
|
Restaino, S.
|
|
|
30 |
S3 |
p. A25
|
artikel
|
| 309 |
59 Racial disparities associated with increasing incidence of epithelial ovarian cancer in the United States
|
Ratnaparkhi, R.
|
|
|
30 |
S3 |
p. A35
|
artikel
|
| 310 |
175 Radiation: cure or curse? A case report on radiation-induced endometrial cancer after cervical cancer treatment
|
Abrenica, J.
|
|
|
30 |
S3 |
p. A76
|
artikel
|
| 311 |
355 Radical vs. simple hysterectomy: a retrospective study on the survival outcomes of cervical cancer patients
|
Rivera, R.
|
|
|
30 |
S3 |
p. A146
|
artikel
|
| 312 |
15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients
|
Rocconi, R.
|
|
|
30 |
S3 |
p. A11-A12
|
artikel
|
| 313 |
280 Rapid response to itraconazole and transcript analysis of the cervical cancer tissue obtained by the sequential biopsy: a case report
|
Takimoto, Y.
|
|
|
30 |
S3 |
p. A114
|
artikel
|
| 314 |
182 Real world experience of pembrolizumab monotherapy in patients with recurrent or persistent cervical cancer: a Korean multi-center retrospective study(KGOG1041)
|
Choi, M.
|
|
|
30 |
S3 |
p. A79
|
artikel
|
| 315 |
400 Real world outcomes of olaparib maintenance therapy in patients with brca1/2-mutated platinum-sensitive epithelial ovarian cancer
|
McLaren, A.
|
|
|
30 |
S3 |
p. A166
|
artikel
|
| 316 |
122 Reconstructive plastic surgery using fasciocutaneous flaps in the surgical treatment of vulvar cancer (193 cases within the 1995-2015 time period)
|
Dikareva, E.
|
|
|
30 |
S3 |
p. A55
|
artikel
|
| 317 |
170 Recurrence of ovarian cancer with distant metastasis after five years: a single institute experience
|
Chew, K.
|
|
|
30 |
S3 |
p. A74-A75
|
artikel
|
| 318 |
60 Recurrent paget’s disease of the vulva in a split-thickness graft
|
Imperio-Onglao, R.
|
|
|
30 |
S3 |
p. A35-A36
|
artikel
|
| 319 |
4 Refining pathologic interpretation of endometrial carcinomas: lessons learned from a nationwide study in a new era of molecular classification
|
Thompson, E.
|
|
|
30 |
S3 |
p. A3-A4
|
artikel
|
| 320 |
167 Reflex methylation testing in endometrial cancer: a single centre retrospective study
|
Honner, M.
|
|
|
30 |
S3 |
p. A73
|
artikel
|
| 321 |
74 Regional review of endometrial cancer outcomes in Kent and Medway, UK
|
Frimpong, D.
|
|
|
30 |
S3 |
p. A41
|
artikel
|
| 322 |
371 Relative conditional survival in women with newly-diagnosed ovarian cancer in the United States: results from the tempus dataset, 1982-2018
|
Szamreta, E.
|
|
|
30 |
S3 |
p. A153-A154
|
artikel
|
| 323 |
474 Resection of perianal CIS with V-Y graft reconstruction
|
Hatch, K.
|
|
|
30 |
S3 |
p. A196
|
artikel
|
| 324 |
246 Restraint stress promotes tumor growth in a syngeneic mouse model of ovarian cancer
|
Aquino-Acevedo, A.
|
|
|
30 |
S3 |
p. A100
|
artikel
|
| 325 |
125 Results of a randomized phase ii trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent chemonaive stromal ovarian tumors
|
Brown, J.
|
|
|
30 |
S3 |
p. A56
|
artikel
|
| 326 |
483 Retroperitoneal bleeding management during laparoscopic lymphadenectomy
|
Ribeiro, J.
|
|
|
30 |
S3 |
p. A198-A199
|
artikel
|
| 327 |
390 Retroperitoneal metastasis of uterine PEComa treated with extended para-aortic lymphadenectomy associated with nephrectomy and aortic resection with prosthetic vascular reconstruction
|
Ribeiro, R.
|
|
|
30 |
S3 |
p. A162
|
artikel
|
| 328 |
276 Review of endometrial cancer management at an upcoming gynaecological oncology unit in India
|
Digumarti, L.
|
|
|
30 |
S3 |
p. A113
|
artikel
|
| 329 |
140 Rising incidence of cervical adenocarcinoma in the United States – who is most at risk?
|
Liao, C.
|
|
|
30 |
S3 |
p. A61
|
artikel
|
| 330 |
30 Risk factors associated with increasing incidence of uterine cancer after correcting for hysterectomy
|
Liao, C.
|
|
|
30 |
S3 |
p. A21-A22
|
artikel
|
| 331 |
478 Robotic assisted laparoscopic resection of rectovaginal clear cell carcinoma mass arising from endometriosis
|
White, M.
|
|
|
30 |
S3 |
p. A197
|
artikel
|
| 332 |
475 Robotic assited inguinpfemoral lymphadenectomy for vulval carcinoma
|
Kulkarni, Y.
|
|
|
30 |
S3 |
p. A196
|
artikel
|
| 333 |
477 Robotic ileal neovagina
|
Ribeiro, R.
|
|
|
30 |
S3 |
p. A197
|
artikel
|
| 334 |
218 Role of frozen section in surgical staging of early – stage endometrial cancer: experience at hospital sotero del rio
|
Pertossi, E.
|
|
|
30 |
S3 |
p. A90
|
artikel
|
| 335 |
204 Role of minimally invasive surgery versus open approach on the clinical and surgical outcome in patients with early stage uterine carcinosarcomas: a retrospective study
|
Corrado, G.
|
|
|
30 |
S3 |
p. A86
|
artikel
|
| 336 |
449 Role of neoadjuvant chemotherapy on local control in locally advanced vulvar carcinoma: a single institution experience
|
Adorni, M.
|
|
|
30 |
S3 |
p. A186-A187
|
artikel
|
| 337 |
372 Safety and activity of the anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer
|
Santin, A.
|
|
|
30 |
S3 |
p. A154
|
artikel
|
| 338 |
17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
|
Freyer, G.
|
|
|
30 |
S3 |
p. A12-A13
|
artikel
|
| 339 |
34 Screening for cervical cancer in women under the age of 25: a cross-sectional study at an university hospital in minas gerais – Brazil
|
Barbosa, L.
|
|
|
30 |
S3 |
p. A23
|
artikel
|
| 340 |
230 Search for predictive biomarkers of sensitivity/resistance against cisplatin in high-grade serous ovarian cancer
|
Cortez, A.
|
|
|
30 |
S3 |
p. A95
|
artikel
|
| 341 |
473 Secondary laparoscopic cytoreduction for recurrent ovarian cancer in case of laparoscopic primary debulking surgery
|
Eom, J.M.
|
|
|
30 |
S3 |
p. A195-A196
|
artikel
|
| 342 |
190 Selecting patients for 3rd line chemotherapy and beyond in epithelial ovarian cancer
|
Seol, A.
|
|
|
30 |
S3 |
p. A82
|
artikel
|
| 343 |
385 Sentinel lymph node biopsy for early stage endometrial and cervical cancer performed by surgeons in training
|
Munhóz, A.
|
|
|
30 |
S3 |
p. A160-A161
|
artikel
|
| 344 |
7 Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade endometrial cancer staging (SENTOR trial): a prospective multicenter cohort study
|
Cusimano, M.
|
|
|
30 |
S3 |
p. A5
|
artikel
|
| 345 |
377 Sentinel lymph node detection in endometrial cancer: laparoscopic versus robotic approach
|
Bizzarri, N.
|
|
|
30 |
S3 |
p. A156-A158
|
artikel
|
| 346 |
156 Sentinel lymph node detection with indocyanine green and patent blue dye in cervical cancer: a retrospective study
|
McBain, R.
|
|
|
30 |
S3 |
p. A68
|
artikel
|
| 347 |
87 Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
|
Laven, P.
|
|
|
30 |
S3 |
p. A45
|
artikel
|
| 348 |
406 Sentinel lymph node in cervical and endometrial cancer: review of the first 58 cases in a university setting
|
Brañes, J.
|
|
|
30 |
S3 |
p. A169
|
artikel
|
| 349 |
77 Sex cord stromal and germ cell ovarian cancer – is there a racial disparity?
|
Liao, C.
|
|
|
30 |
S3 |
p. A42
|
artikel
|
| 350 |
188 Sex cord tumor with annular tubules: about four cases
|
Ben Hamida, K.
|
|
|
30 |
S3 |
p. A81-A82
|
artikel
|
| 351 |
124 Simple vaginal trachelectomy in women with early-stage low risk cervical cancer who wish to preserve fertility: the new standard of care ?
|
Plante, M.
|
|
|
30 |
S3 |
p. A56
|
artikel
|
| 352 |
Simvastatin modifies the internalization, endocytic trafficking, and the content of ovarian cancer cellderived extracellular microvesicles which are responsible of inducing migration and invasion in vitro
|
Mancilla, P.
|
|
|
30 |
S3 |
p. A192-A193
|
artikel
|
| 353 |
212 Single-agent amrubicin therapy for recurrent small cell neuroendocrine cervical carcinoma
|
Minobe, S.
|
|
|
30 |
S3 |
p. A89
|
artikel
|
| 354 |
117 Slovenian experience with bevacizumab in first-line treatment of epithelial ovarian cancer
|
Gregorič, B.
|
|
|
30 |
S3 |
p. A53-A54
|
artikel
|
| 355 |
447 Stage one endometrial cancer. Concept extensions of risk group
|
Mavrichev, S.
|
|
|
30 |
S3 |
p. A185
|
artikel
|
| 356 |
333 Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited setting
|
Wong, J.
|
|
|
30 |
S3 |
p. A135
|
artikel
|
| 357 |
476 Standard laparoscopic bilateral pelvic sentinel lymph node detection with radiotracer, blue dye and permanent instruments
|
Munhóz, A.
|
|
|
30 |
S3 |
p. A196-A197
|
artikel
|
| 358 |
253 Stereotactic ablative radiotherapy in oligometastatic gynaecological malignancies
|
El-Modir, A.
|
|
|
30 |
S3 |
p. A103
|
artikel
|
| 359 |
448 Struma ovarii: a rare ovarian malignancy masquerading as a dermoid cyst. A case report
|
Addley, S.
|
|
|
30 |
S3 |
p. A185-A186
|
artikel
|
| 360 |
454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)
|
Krämer, P.
|
|
|
30 |
S3 |
p. A188-A189
|
artikel
|
| 361 |
73 Study of lipid profile and thyroid hormones in patients with uterine fibroids
|
Peshkova, T.
|
|
|
30 |
S3 |
p. A41
|
artikel
|
| 362 |
351 Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early stage endometrial cancer
|
Tortorella, L.
|
|
|
30 |
S3 |
p. A144-A145
|
artikel
|
| 363 |
142 Surgeon-administered ilio-inguinal and pudendal nerve blocks for vulval oncology surgery: an evaluation with visual analogue pain scoring
|
Maguire, P.
|
|
|
30 |
S3 |
p. A62
|
artikel
|
| 364 |
480 Surgery for rectosigmoid peritonectomy in advanced ovarian cancer: surgical technique of visceral segmental serosectomy and 8-year experience
|
Park, S.J.
|
|
|
30 |
S3 |
p. A198
|
artikel
|
| 365 |
305 Surgical complexity and intra-operative fluid management influence duration of ICU care following cytoreductive surgery
|
Collins, A.
|
|
|
30 |
S3 |
p. A124
|
artikel
|
| 366 |
285 Surgical morbidity during COVID-19 pandemic – a gynaecology oncology persective
|
Moran, S.
|
|
|
30 |
S3 |
p. A116
|
artikel
|
| 367 |
341 Surgical morbidity of laparoscopic vs. open surgery for Borderline Ovarian Tumors: a single center analysis
|
Oltolina, N.
|
|
|
30 |
S3 |
p. A139
|
artikel
|
| 368 |
399 Surgical morbidity of the retroperitoneal staging in patients undergoing surgery for early stage epithelial ovarian cancer
|
Dri, M.
|
|
|
30 |
S3 |
p. A165-A166
|
artikel
|
| 369 |
281 Surgical results of abdominal versus minimally invasive radical hysterectomy for cervical cancer in San Borja clinical hospital Santiago of Chile
|
Ibacache, J.
|
|
|
30 |
S3 |
p. A115
|
artikel
|
| 370 |
419 Survival after minimally invasive surgery in early cervical cancer: is the uterine manipulator to blame?
|
Nica, A.
|
|
|
30 |
S3 |
p. A175
|
artikel
|
| 371 |
53 Survival and oncological outcomes in the elderly patients with endometrial carcinoma
|
Shoraka, M.
|
|
|
30 |
S3 |
p. A32-A33
|
artikel
|
| 372 |
31 Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: long-term results of a propensity-matched analysis
|
Bogani, G.
|
|
|
30 |
S3 |
p. A22
|
artikel
|
| 373 |
183 Survival role of lymphadenectomy in patients surgically treated for apparent early-stage epithelial ovarian cancer
|
Lembo, A.
|
|
|
30 |
S3 |
p. A79-A80
|
artikel
|
| 374 |
446 Synchronous tumors of endometrium and unilateral fallopian tube: a rare case report
|
Parroco, M.
|
|
|
30 |
S3 |
p. A185
|
artikel
|
| 375 |
121 Systemic immune-inflammatory index (SII) as a prognostic factor for cervical cancer recurrence
|
De Guzman, A.
|
|
|
30 |
S3 |
p. A54-A55
|
artikel
|
| 376 |
159 Target therapy in heavily pretreated women affected by different cancers: a preliminary single center experience after the introduction of comprehensive genomic profiling in clinical practice
|
Cappuccio, S.
|
|
|
30 |
S3 |
p. A69-A70
|
artikel
|
| 377 |
486 Techniques of quadrant wise cytoreductive surgery in advanced epithelial ovarian cancer: total parietal peritonectomy + retrograde hysterectomy + mesentric stripping & glissons capsulectomy
|
Somashekhar, S.P.
|
|
|
30 |
S3 |
p. A199-A200
|
artikel
|
| 378 |
178 The accuracy of ultrasound in diagnosing first trimester molar pregnancy
|
Medalla, R.
|
|
|
30 |
S3 |
p. A77-A78
|
artikel
|
| 379 |
375 The changing nature of referral pathways for risk reducing salpingo-oophorectomy in a UK cancer centre
|
Smallwood, K.
|
|
|
30 |
S3 |
p. A156
|
artikel
|
| 380 |
324 The complexity of decision-making for risk-reducing surgery in women with lynch syndrome
|
Cun, H.
|
|
|
30 |
S3 |
p. A130-A131
|
artikel
|
| 381 |
147 The development of three-dimensional platform for patient-derived ovarian cancer tissue remodelling. A systematic literature review
|
Sevinyan, L.
|
|
|
30 |
S3 |
p. A64-A65
|
artikel
|
| 382 |
426 The diagnostic value of microRNA signature in endometrial cancer
|
Donkers, H.
|
|
|
30 |
S3 |
p. A177-A178
|
artikel
|
| 383 |
248 The experience in pelvic exenteration in patients with advanced and recurrent cervical cancer in Belarus
|
Matylevich, O.
|
|
|
30 |
S3 |
p. A101
|
artikel
|
| 384 |
135 The fertility after choriocarcinoma in young women
|
Kaabia, O.
|
|
|
30 |
S3 |
p. A60
|
artikel
|
| 385 |
261 The impact of histology and adjuvant therapy on survival and recurrence patterns among high-grade endometrial cancer with retroperitoneal metastases
|
McEachron, J.
|
|
|
30 |
S3 |
p. A106-A107
|
artikel
|
| 386 |
160 The impact of hysteroscopy on the disease course of high grade endometrial carcinoma
|
Larish, A.
|
|
|
30 |
S3 |
p. A70
|
artikel
|
| 387 |
52 The impact of the surgery for breast cancer in young women on their couple’s relationship
|
Kaabia, O.
|
|
|
30 |
S3 |
p. A32
|
artikel
|
| 388 |
370 The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer
|
Kim, S.
|
|
|
30 |
S3 |
p. A152-A153
|
artikel
|
| 389 |
295 The importance of biomarker expression in addition to lymph node status in the ESMO risk stratification of endometrial cancer
|
Vrede, S.
|
|
|
30 |
S3 |
p. A120-A122
|
artikel
|
| 390 |
360 The increasing incidence of carcinosarcoma of the ovary and fallopian tube in the united states: who is most at risk?
|
Ratnaparkhi, R.
|
|
|
30 |
S3 |
p. A148
|
artikel
|
| 391 |
131 The increasing racial disparity of uterine carcinosarcoma over 16 years: a study of 35,000 patients
|
Liao, C.
|
|
|
30 |
S3 |
p. A58-A59
|
artikel
|
| 392 |
10 The learning curve of robot-assisted laparoscopy has impact on the oncological outcomes of early stage cervical cancer patients
|
Baeten, I.
|
|
|
30 |
S3 |
p. A7-A8
|
artikel
|
| 393 |
412 T helper cell 17 is inversely related to clinical outcome to neoadjuvant chemotherapy in ovarian cancer
|
Lou, G.
|
|
|
30 |
S3 |
p. A171
|
artikel
|
| 394 |
245 The metaxas’s hospital thromboprophylaxis program in oncological & surgical patients – methos [ClinicalTrials.gov: NCT04248348]. Intermediate results for gynecological cancer patients undergoing surgery
|
Fotiou, A.
|
|
|
30 |
S3 |
p. A99-A100
|
artikel
|
| 395 |
179 The prevalence of CIN II-III in positive visual inspection using acetic acid (VIA) at a tertiary government hospital
|
Parroco, M.
|
|
|
30 |
S3 |
p. A78
|
artikel
|
| 396 |
90 The protein expression of TNFR2 and STAT3 in high-grade serous ovarian cancer (HGSC) tissue and its association with platinum sensitivity
|
Kampan, N.
|
|
|
30 |
S3 |
p. A47
|
artikel
|
| 397 |
27 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer
|
Bizzarri, N.
|
|
|
30 |
S3 |
p. A19-A20
|
artikel
|
| 398 |
70 The relationship between pre-operative lymphocyte monocyte ratio and serum cancer antigen-125 among women with epithelial ovarian cancer in Lagos university teaching hospital, Lagos, Nigeria
|
Soibi-Harry, A.
|
|
|
30 |
S3 |
p. A39-A40
|
artikel
|
| 399 |
150 The survival outcome and prognostic factors of early stage ovarian cancer, FIGO stage IA and IC, after fertility-sparing surgery (FSS): a retrospective cohort study
|
Agulto-Mercadal, M.
|
|
|
30 |
S3 |
p. A65-A67
|
artikel
|
| 400 |
392 The uptake and impact of HPV vaccination on cervical cancer incidence 10 years after FDA approval in United States
|
Liao, C.
|
|
|
30 |
S3 |
p. A163
|
artikel
|
| 401 |
438 The use of neoadjuvant chemotherapy in advanced endometrial cancer
|
Philp, L.
|
|
|
30 |
S3 |
p. A181-A182
|
artikel
|
| 402 |
444 The use of sentinellymphnodebiopsy in the treatment of breastductalcarcinoma in situ
|
Sakhri, S.
|
|
|
30 |
S3 |
p. A184
|
artikel
|
| 403 |
105 Time intervals from the first symptom to surgery of ovarian malignancies in a tertiary hospital
|
Ortega, M.
|
|
|
30 |
S3 |
p. A50-A51
|
artikel
|
| 404 |
258 Total retroperitoneal en bloc resection of multivisceral-peritoneal packet (TROMP operation): a novel surgical technique for advanced ovarian cancer; retrospective analysis of a prospective collected database
|
Muallem, M.
|
|
|
30 |
S3 |
p. A104-A106
|
artikel
|
| 405 |
420 Transcriptome analysis of glassy cell carcinoma and mucinous adenocarcinoma compared with squamous cell carcinoma of uterine cervix
|
Ishizuka, Y.
|
|
|
30 |
S3 |
p. A175
|
artikel
|
| 406 |
337 Treatment of ovarian cancer via induction of cellular stress and the unfolded protein response (UPR)
|
Paridon, A.
|
|
|
30 |
S3 |
p. A136-A137
|
artikel
|
| 407 |
402 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study
|
Sivakumaran, T.
|
|
|
30 |
S3 |
p. A166-A167
|
artikel
|
| 408 |
403 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study
|
Sivakumaran, T.
|
|
|
30 |
S3 |
p. A167
|
artikel
|
| 409 |
236 Tumor size as independent prognostic factor in stage IA endometrioid endometrial adenocarcinoma
|
Co, G.
|
|
|
30 |
S3 |
p. A97
|
artikel
|
| 410 |
84 Umbilical metastasis of an endometrial carcinoma: a case report
|
Sá, I.
|
|
|
30 |
S3 |
p. A44
|
artikel
|
| 411 |
5 Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study
|
Kim, S.
|
|
|
30 |
S3 |
p. A4
|
artikel
|
| 412 |
291 Unique case series of coexisting endometrial and hematologic malignancies
|
Leiva, S.
|
|
|
30 |
S3 |
p. A117-A118
|
artikel
|
| 413 |
232 Unravelling cervical adenosarcoma
|
Rivera, R.
|
|
|
30 |
S3 |
p. A95-A96
|
artikel
|
| 414 |
82 Unusual extrauterine localisation of low grade endometrial stromal sarcoma : report of two cases
|
Slimene, M.
|
|
|
30 |
S3 |
p. A43-A44
|
artikel
|
| 415 |
148 Unusual localizations of metastasis from lobular breast carcinoma: a case report
|
Fertani, Y.
|
|
|
30 |
S3 |
p. A65
|
artikel
|
| 416 |
176 Uptake of breast cancer screening strategies in epithelial ovarian cancer patients with BRCA1/2 mutation
|
Kim, S.
|
|
|
30 |
S3 |
p. A76
|
artikel
|
| 417 |
239 Use of sentinel lymph node mapping for gynaecological cancer: one centre experience
|
Eltermaa, M.
|
|
|
30 |
S3 |
p. A98
|
artikel
|
| 418 |
129 Uterine lipoleimyoma miming ovarian teratoma: a diagnosis challenge
|
Ben Hamida, K.
|
|
|
30 |
S3 |
p. A57-A58
|
artikel
|
| 419 |
479 Uterine transposition in a case of rectal malignancy
|
OBrien, M.
|
|
|
30 |
S3 |
p. A197
|
artikel
|
| 420 |
231 Utilization of immunotherapy among eligible patients with cervical cancer
|
Smith, M.
|
|
|
30 |
S3 |
p. A95
|
artikel
|
| 421 |
186 Validation of the HPV impact profile (HIP) in lebanese women with human papilloma virus or associated lesions
|
Atallah, D.
|
|
|
30 |
S3 |
p. A80-A81
|
artikel
|
| 422 |
6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?
|
Thompson, E.
|
|
|
30 |
S3 |
p. A5
|
artikel
|
| 423 |
327 Venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer
|
Black, K.
|
|
|
30 |
S3 |
p. A133
|
artikel
|
| 424 |
467 VNOTES (vaginal natural orifices transluminal endoscopic surgery) for Ia1 cervical carcinoma
|
Badiglian-Filho, L.
|
|
|
30 |
S3 |
p. A193-A194
|
artikel
|
| 425 |
211 Vulvar and vaginal metastasis of sigmoid adenocarcinoma: a rare localization
|
Fertani, Y.
|
|
|
30 |
S3 |
p. A89
|
artikel
|
| 426 |
51 Would a multi-ethnic Asian female population take up self-sampling HPV testing as a routine cervical screening method?
|
Khoo, S.
|
|
|
30 |
S3 |
p. A32
|
artikel
|
Tijdschrift beschrijving